Baby botulism outbreak: FDA still doesn't know cause, or how to prevent it

Article excerpt

The FDA concluded its investigation into a botulism outbreak linked to ByHeart baby formula without determining how bacterial spores contaminated the product or how to prevent future incidents. The agency traced the contamination to specific batches but stopped short of identifying its origin, announcing only that it would continue focusing on ingredient sources. Critics called the outcome insufficient, highlighting a significant gap in the regulator's ability to protect infants from similar threats.